Credit to Coolreit on the IV Energy Investing board for this Ivermectin trial link
Ivermection is a generic drug that costs $1-2 per treatment. 83% reduction in Covid mortality in preliminary trial results. n = 1452. Next 6 weeks will double the number of patients in trial.
https://www.youtube.com/watch?v=yOAh7GtvcOs&feature=emb_title
WHO-commissioned review of ivermectin trials finds 83% reduction in covid mortality.
Published: December 31, 2020
Share on: Twitter / Facebook
Select Language
English
Dutch
French
German
Greek
Hebrew
Hungarian
Italian
Japanese
Polish
Portuguese
Russian
Spanish
Swedish
Turkish
Powered by
WHO-commissioned review of ivermectin trials finds 83% reduction in covid mortality.
Dr Andrew Hill of the Department of Pharmacology at the University of Liverpool (UK) is currently performing a WHO-commissioned review and meta-analysis of randomized controlled trials of ivermectin against covid. In the following 12-minute video, Dr Hill is presenting his preliminary results, which confirm a highly significant 83% reduction in covid mortality (95% CI 65%-92%).
This result is based on in-hospital trials, so it doesn’t even take into account early ambulatory and prophylactic treatment. The WHO now wants to wait for three more trials, due to be published sometime in January, before issuing an official recommendation. At the end of his presentation, Dr Hill speaks of ivermectin as a potentially “transformational treatment”.